Interaction Between Placebo Response and Subjects’ Decision to Dose Escalate in a Trial of Flexible-Dose Antimuscarinic Treatment for Overactive Bladder Symptoms

Abstract Category

Pharmacology: Clinical

Links
	Abstract 616
	Non-Discussion Posters Scientific Non Discussion Poster Session 31
	1. Tufts University School of Medicine, 2. AMC, University of Amsterdam, 3. Pfizer Inc
Abstract PDF Edit Abstract Abstract Centre